tiprankstipranks
Trending News
More News >
Haemonetics Corp. (HAE)
NYSE:HAE
US Market

Haemonetics (HAE) Ratios

Compare
431 Followers

Haemonetics Ratios

HAE's free cash flow for Q3 2026 was $0.56. For the 2026 fiscal year, HAE's free cash flow was decreased by $ and operating cash flow was $0.20. See a summary of the company’s cash flow.
Ratios
TTM
Mar 25Mar 24Mar 23Mar 22
Liquidity Ratios
Current Ratio
1.75 1.62 2.56 3.06 1.71
Quick Ratio
1.15 0.99 1.50 2.03 1.05
Cash Ratio
0.67 0.53 0.60 1.13 0.59
Solvency Ratio
0.18 0.17 0.17 0.18 0.12
Operating Cash Flow Ratio
0.63 0.31 0.61 1.08 0.39
Short-Term Operating Cash Flow Coverage
1.11 0.60 17.77 23.17 0.80
Net Current Asset Value
$ -635.76M$ -695.14M$ -466.73M$ -347.11M$ -354.28M
Leverage Ratios
Debt-to-Assets Ratio
0.49 0.50 0.37 0.40 0.42
Debt-to-Equity Ratio
1.34 1.49 0.84 0.94 1.04
Debt-to-Capital Ratio
0.57 0.60 0.46 0.48 0.51
Long-Term Debt-to-Capital Ratio
0.50 0.53 0.45 0.48 0.43
Financial Leverage Ratio
2.73 2.99 2.29 2.37 2.48
Debt Service Coverage Ratio
1.00 0.99 11.23 8.56 0.74
Interest Coverage Ratio
12.66 22.76 12.67 10.67 4.72
Debt to Market Cap
0.44 0.39 0.19 0.18 0.24
Interest Debt Per Share
26.60 24.53 16.19 15.37 15.63
Net Debt to EBITDA
2.29 2.58 2.13 1.91 2.72
Profitability Margins
Gross Profit Margin
58.49%57.21%54.38%53.30%53.44%
EBIT Margin
19.94%18.16%15.80%14.31%10.59%
EBITDA Margin
28.48%26.16%22.57%21.56%19.30%
Operating Profit Margin
19.21%16.30%12.60%13.35%8.13%
Pretax Profit Margin
17.23%15.58%11.60%12.10%6.41%
Net Profit Margin
13.31%12.32%8.98%9.87%4.37%
Continuous Operations Profit Margin
13.31%12.32%8.98%9.87%4.37%
Net Income Per EBT
77.23%79.07%77.41%81.61%68.17%
EBT Per EBIT
89.70%95.61%92.10%90.62%78.80%
Return on Assets (ROA)
7.04%6.84%5.35%5.96%2.33%
Return on Equity (ROE)
20.26%20.43%12.25%14.11%5.79%
Return on Capital Employed (ROCE)
12.98%11.84%8.70%9.27%5.70%
Return on Invested Capital (ROIC)
8.67%8.06%6.70%7.51%3.36%
Return on Tangible Assets
11.98%12.06%9.60%9.67%4.01%
Earnings Yield
6.30%5.27%2.73%2.75%1.34%
Efficiency Ratios
Receivables Turnover
6.74 6.71 6.34 6.52 6.23
Payables Turnover
11.24 8.69 8.14 8.54 7.92
Inventory Turnover
1.70 1.59 1.88 2.10 1.58
Fixed Asset Turnover
4.44 4.79 3.57 3.76 3.84
Asset Turnover
0.53 0.56 0.60 0.60 0.53
Working Capital Turnover Ratio
3.49 3.30 2.65 2.81 2.64
Cash Conversion Cycle
235.94 241.25 206.64 186.66 243.79
Days of Sales Outstanding
54.19 54.36 57.60 55.95 58.57
Days of Inventory Outstanding
214.23 228.89 193.89 173.46 231.29
Days of Payables Outstanding
32.48 42.00 44.84 42.75 46.07
Operating Cycle
268.42 283.24 251.48 229.41 289.86
Cash Flow Ratios
Operating Cash Flow Per Share
7.24 3.61 3.58 5.38 3.37
Free Cash Flow Per Share
6.58 2.83 2.28 3.21 1.48
CapEx Per Share
0.66 0.78 1.31 2.17 1.89
Free Cash Flow to Operating Cash Flow
0.91 0.78 0.64 0.60 0.44
Dividend Paid and CapEx Coverage Ratio
11.01 4.63 2.74 2.48 1.78
Capital Expenditure Coverage Ratio
11.01 4.63 2.74 2.48 1.78
Operating Cash Flow Coverage Ratio
0.28 0.15 0.22 0.36 0.22
Operating Cash Flow to Sales Ratio
0.26 0.13 0.14 0.23 0.17
Free Cash Flow Yield
11.07%4.48%2.69%3.88%2.35%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
15.88 18.97 36.57 36.41 74.40
Price-to-Sales (P/S) Ratio
2.11 2.34 3.28 3.60 3.25
Price-to-Book (P/B) Ratio
3.06 3.87 4.48 5.14 4.31
Price-to-Free Cash Flow (P/FCF) Ratio
9.04 22.33 37.24 25.80 42.60
Price-to-Operating Cash Flow Ratio
8.22 17.50 23.66 15.39 18.73
Price-to-Earnings Growth (PEG) Ratio
2.60 0.44 16.60 0.22 -1.62
Price-to-Fair Value
3.06 3.87 4.48 5.14 4.31
Enterprise Value Multiple
9.71 11.51 16.68 18.59 19.55
Enterprise Value
3.65B 4.10B 4.93B 4.68B 3.75B
EV to EBITDA
9.71 11.51 16.68 18.59 19.55
EV to Sales
2.77 3.01 3.76 4.01 3.77
EV to Free Cash Flow
11.83 28.77 42.69 28.76 49.48
EV to Operating Cash Flow
10.76 22.55 27.12 17.15 21.76
Tangible Book Value Per Share
-2.46 -4.75 -0.22 1.50 -0.55
Shareholders’ Equity Per Share
19.48 16.31 18.93 16.11 14.68
Tax and Other Ratios
Effective Tax Rate
0.23 0.21 0.23 0.18 0.32
Revenue Per Share
28.17 27.04 25.82 23.01 19.46
Net Income Per Share
3.75 3.33 2.32 2.27 0.85
Tax Burden
0.77 0.79 0.77 0.82 0.68
Interest Burden
0.86 0.86 0.73 0.85 0.61
Research & Development to Revenue
0.05 0.05 0.05 0.05 0.06
SG&A to Revenue
0.00 0.30 0.32 0.31 0.33
Stock-Based Compensation to Revenue
0.02 0.02 0.02 0.02 0.02
Income Quality
1.93 1.08 1.55 2.37 3.97
Currency in USD